HOME >> BIOLOGY >> NEWS
Gene mutation protecting against malaria linked to prostate cancer incidence in African-American men

A University of Cincinnati College of Medicine suggests that the 60 percent greater incidence of prostate cancer among African-American men is related to a gene mutation developed generations ago in West Africa as nature's way of providing protection from the malaria infection endemic in that part of the world. Approximately 70 percent of African-Americans have the mutation. The preclinical study was presented Tuesday, April 5, at the American Society of Investigative Pathology sessions of Experimental Biology 2005.

The gene mutation prevents expression of the Duffy antigen/receptor for chemokines (DARC) on red blood cells. The DARC originally was described by scientists as a red blood cell receptor required for infection by the malarial parasite. More recent evidence, however, suggests that the DARC may also play a role in preventing or slowing the formation of new blood vessels produced by tumors in order to gain nutrients needed to grow.

Dr. Alex B. Lentsch says this is an important first step towards identifying a causative factor for the higher prevalence of prostate cancer in African-American men as well as their two-fold higher mortality than white men. His study suggests that prostate cancer in men with a mutated DARC gene would develop more quickly to the level of detection and grow more aggressively.

These pre-clinical studies will need to be validated in prostate cancer patients, he adds. But once that is done, a simple blood test measuring the presence or absence of the DARC on red blood cells could be used to identify prostate cancer patients at higher risk for aggressive growth of the tumor. It is also possible that anti-chemokine therapies could be tested and applied to these patients.

Tumor angiogenesis occurs when tumor cells release small compounds or angiogenic factors that cause existing blood vessels to grow into the tumor. One class of angiogenic factors released by prostate tumors are chemokines, small protei
'"/>

Contact: Sylvia Wrobel
ebpress@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
4-Apr-2005


Page: 1 2

Related biology news :

1. New gene mutation identified in common type of dementia
2. Researchers identify genetic mutation that may alter tumor cell proliferation
3. p53 gene mutations and inflammation trigger skin cancer
4. Muscle weakness: New mutation identified
5. Researchers discover inherited mutation for leukemia
6. Gene mutation linked to cognition is found only in humans
7. Gene mutation linked to increased athletic performance in whippets
8. Researchers learn more about genetic mutation linked to autism
9. Researchers find gene mutation that causes infertility in male mice
10. Gene mutations linked to hereditary lung disease
11. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... ... solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments ... Senior Fellows are charged with supporting the organization’s initiatives and overall vision. , ...
(Date:6/28/2020)... JUPITER, Fla. (PRWEB) , ... June 25, 2020 , ... ... will focus on innovations in accelerated Point of Care Testing solutions (POCT). Check local ... labs. Samples are collected at medical offices and are shipped to labs throughout the ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that the company has received ISO9001:2015 certification for the development ... research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly ... closed on the purchase of greenfield for a new, expanded manufacturing facility. The ... 21 acres in the initial acquisition, with an option to purchase an additional ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics ... , Known as MediVet Biologics since its formation in 2016, the company ... Ardent Animal Health will build on its base of innovative therapies for osteoarthritis and ...
(Date:7/31/2020)... ... July 29, 2020 , ... G-CON Manufacturing, the leader in ... “BUILDING FOR LIFE.” The adoption of this taglines comes at a time of ... capacity to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet ... to three different materials for use with CRM, neurostimulation, vascular, and related devices. ... to meet specific design requirements, performance, and cost criteria; especially where solid wire ...
Breaking Biology Technology:
Cached News: